Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: GlobalData
$125.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Renaissance and Glaxosmithkline Plc Agree To Transfer Of Nine Products


Monday, 3 Jun 2013 12:10pm EDT 

Renaissance Acquisition Holdings, LLC (Renaissance), a RoundTable Healthcare Partners (RoundTable) portfolio company, and Glaxosmithkline Plc announced that they have entered into an agreement giving Renaissance the rights in the USA to manufacture, market and sell six dermatology and three anti-viral products from GSK. 

Company Quote

47.71
-0.22 -0.46%
3 Mar 2015